Clinical trial · NCT06304129 · NOT_YET_RECRUITING · NA
Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers
Sponsor: Central Hospital, Nancy, France
Summary
.The goal of this interventional study is to estimate the diagnostic performance of plasma biomarkers of interest (Aβ40 and Aβ42, P-Tau and NFL), enabling discrimination between patients with and without a pathophysiological AD process. The main questions it aims to answer are: * to define a threshold value for each of the plasma, * to describe the correlations between the plasma biomarkers of interest and the other biological analyses performed as part of care, in particular triglyceridemia, cholesterolemia, glycemia and proteinemia, * to describe biomarker results in relation to comorbidities, in particular dyslipidemia and diabetes * to describe the final diagnosis and results obtained for plasma biomarkers, for patients with intermediate results according to the A/T/N classification (A-/T+ or A+/T-) Participants will be selected among patients undergoing lumbar puncture for the differential diagnosis of AD at Nancy University Hospital.
Interventions
- Blood ponction · DIAGNOSTIC_TEST
Blood ponction
Published eligibility criteria
Verbatim from the registry. Only the site can decide how these apply to a specific patient.
Inclusion Criteria: * Man or woman aged 18 or over * Person affiliated to a social security scheme or beneficiary of such a scheme * Person who has received full information on the organization of the research and has signed an informed consent form * Person whose care requires a lumbar puncture to measure markers of Alzheimer's disease Exclusion Criteria: * Adult subject to a legal protection measure (guardianship, curatorship, safeguard of justice) * An adult unable to give consent * Persons deprived of their liberty by judicial or administrative decision * Persons under psychiatric care under articles L. 3212-1 and L. 3213-1. * Pregnant, parturient or breast-feeding women * Persons staying in a health or social establishment for purposes other than research.
Sites (1)
- CHRU De Nancy, Nancy, Grand Est, France
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2024-03-12.